Q1 2021 TFF Pharmaceuticals Inc Earnings Call Transcript
Thank you for standing by, and welcome to the TFF Pharmaceuticals, Inc. First Quarter 2021 Financial and Business Results Conference Call. (Operator Instructions) As a reminder, today's program may be recorded. And now I'd like to introduce your host for today's program, Paul Sagan, Investor Relations. Please go ahead, sir.
Thank you, operator. Hello, everyone, and welcome to TFF Pharmaceuticals' First Quarter 2021 Financial and Business Results Conference Call. With me on the line today is Glenn Mattes, President and CEO of TFF; Kirk Coleman, Chief Financial Officer; Dr. Dale Christensen, TFF's Director of Clinical Development; Dr. Bill Williams of the University of Texas at Austin; and Chris Cano, TFF's Chief Operating Officer.
A press release announcing our first quarter results is available on the TFF Pharmaceuticals' website. Please take a moment to read the disclaimer about forward-looking statements in the press release. The earnings release and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |